Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Kramer Robin. Insider active across 1 company, notably BIOGEN INC.. In total, 19 disclosures have been published. Activity tracked since 1 July 2021. The latest transaction was disclosed on 6 February 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Kramer Robin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
251 shares@ US$348.9283.5% of flowCommon StockSEC:0001127602-21-021266:0
19 of 19 declarations
About Kramer Robin
Kramer Robin is a declarant linked to BIOGEN INC. (XNAS), where the listed role is Chief Financial Officer. They have 19 filings in total, and across the 19 sampled filings, the observed dates run from 2021-07-02 to 2026-02-10, with a modal transaction nature of option exercise and buy and sell volumes of EUR 0 each.